Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Statistical approaches to stability protocol design.

J T Carstensen1, M Franchini, K Ertel

  • 1University of Wisconsin School of Pharmacy, Madison 53706.

Journal of Pharmaceutical Sciences
|March 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mechanical hysteroscopic tissue removal or hysteroscopic morcellator: understanding the past to predict the future. A narrative review.

Facts, views & vision in ObGyn·2021
Same author

Search for Displaced Leptons in sqrt[s]=13  TeV pp Collisions with the ATLAS Detector.

Physical review letters·2021
Same author

Mortality from COVID-19.

Annali di igiene : medicina preventiva e di comunita·2021
Same author

Longitudinal Flow Decorrelations in Xe+Xe Collisions at sqrt[s_{NN}]=5.44  TeV with the ATLAS Detector.

Physical review letters·2021
Same author

Search for Dark Matter Produced in Association with a Dark Higgs Boson Decaying into W^{±}W^{∓} or ZZ in Fully Hadronic Final States from sqrt[s]=13  TeV pp Collisions Recorded with the ATLAS Detector.

Physical review letters·2021
Same author

The impact of social complexity on the visual exploration of others' actions in preschoolers with autism spectrum disorder.

BMC psychology·2021
Same journal

Green, renewable, or low-carbon? A framework for informed solvent selection in pharmaceutical sciences.

Journal of pharmaceutical sciences·2026
Same journal

Theranostic potential of ramucirumab functionalized magnetoliposomes for targeted delivery of sorafenib and MRI.

Journal of pharmaceutical sciences·2026
Same journal

Intranasal mucoadhesive chitosan microspheres of ranolazine: Formulation, design, and pharmacokinetic evaluation.

Journal of pharmaceutical sciences·2026
Same journal

Evolving landscape of drug development for pediatric rare diseases-from successes to strategies for addressing unmet needs.

Journal of pharmaceutical sciences·2026
Same journal

A mathematical framework for predicting tablet weight variability from blend particle size distribution and tooling geometry.

Journal of pharmaceutical sciences·2026
Same journal

Recrystallization can stop nitrosamine formation in ranitidine hydrochloride.

Journal of pharmaceutical sciences·2026
See all related articles

This study advocates for determining drug stability mechanisms before statistical analysis in preformulation. Understanding the stability profile ensures accurate data interpretation and avoids misclassification of degradation kinetics.

Area of Science:

  • Pharmaceutical Sciences
  • Physical Chemistry
  • Drug Development

Background:

  • Current stability protocols often analyze data retrospectively after accumulation.
  • "Statistically best fit" approaches can lead to inaccurate kinetic order assignments (zero-order vs. first-order).
  • This can misrepresent batch stability and degradation pathways.

Purpose of the Study:

  • To emphasize the importance of establishing stability mechanisms during preformulation.
  • To propose a scientifically rigorous approach for stability evaluation.
  • To improve the accuracy of stability data interpretation in drug development.

Main Methods:

  • Proposes determining the intrinsic stability profile (mechanism) prior to statistical analysis.
  • Illustrates application using pH profiles, Arrhenius plotting, and dissolution data.

Related Experiment Videos

  • Suggests employing fractional factorials (matrix approach) for pH profile analysis.

    • Main Results:

    • A priori determination of stability mechanisms provides a more scientifically sound basis for analysis.
    • This approach allows for a clearer understanding of degradation kinetics.
    • Avoids mischaracterization of drug product stability based solely on statistical fitting.

    Conclusions:

    • Establishing the stability profile (mechanism) at the preformulation stage is scientifically advantageous.
    • This method enhances the reliability of stability data and kinetic order determination.
    • Leads to more accurate predictions of drug product shelf-life and performance.